Skip to content

Artificial intelligence–driven hypertension risk prediction and clinical validation study

Artificial intelligence–driven hypertension risk prediction and clinical validation study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119398
Enrollment
Unknown
Registered
2026-02-26
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Gold Standard:Cardiology experts make judgments based on complete medical records
Index test:Deep Learning Model Based on Transformer Architecture

Sponsors

Handan First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or older. 2. Reason for examination includes routine health check, inpatient assessment, pre-operative assessment, or follow-up for non-acute cardiovascular symptoms. 3. Possession of a digital posteroanterior (PA) or posteroanterior + lateral chest radiograph meeting quality control standards. 4. Possession of reliable clinic blood pressure measurements (or ambulatory blood pressure monitoring results) conforming to clinical guidelines, within 14 days before or after the chest radiograph examination. 5. Possession of sufficient electronic medical record data (or supplemented by structured questionnaires) to complete ESC cardiovascular risk stratification for hypertension (including laboratory tests such as blood glucose, blood lipids, creatinine, and medical history such as diabetes, history of cardiovascular disease, etc.).

Exclusion criteria

Exclusion criteria: 1. Chest X-ray quality is inadequate (severe rotation, insufficient inspiration, metallic artefact, incomplete image). 2. Chest X-ray reveals acute cardiopulmonary disease (e.g., large pleural effusion, pneumothorax, pneumonic consolidation) that may significantly affect cardiac silhouette assessment. 3. An implanted cardiac pacemaker, defibrillator, or other significant implant affecting the mediastinal contour is present (coronary artery stents alone are not exclusionary). 4. Significant clinical data is missing, precluding determination of blood pressure grading or ESC risk stratification. 5. Pregnant or breastfeeding women. 6. Participation in other interventional clinical trials that could interfere with blood pressure assessment.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Area Under the Receiver Operating Characteristic Curve;Specificity;

Secondary

MeasureTime frame
Additional detection rate;

Countries

China

Contacts

Public ContactMengdan Miao

Handan First Hospital

m18032936267@163.com+86 180 3293 6267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026